Searched for
OLOPATADINE HYDROCHLORIDE
These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 27%- These large- and mid-cap stocks can give more than 25% return in 1 year, according to analysts
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%
- Will the currency cycle help them? Yes, but very selectively: 10 pharma stocks with upside potential of up to 33%The biggest mistake made in currency cycles is to confuse revenue gain with pure earnings gain. A company may report stronger rupee revenue...28 Mar, 2026, 12.24 PM IST
- Dr Reddy's shares jump 5% despite 14% YoY fall in Q3 profit. Should you buy, sell or hold?Dr Reddy's shares: The company posted a 14% year-on-year decline in consolidated net profit to Rs 1,210 crore.22 Jan, 2026, 09.45 AM IST
- Dr Reddy's Laboratories Q3 Results: Profit falls 14% YoY to Rs 1,210 crore, revenue up 4%Dr Reddy’s Laboratories reported a 14% YoY drop in Q3 net profit to Rs 1,210 crore, even as revenue rose 4% to Rs 8,727 crore. Lower margin...21 Jan, 2026, 05.27 PM IST
- Dr Reddy's launches generic OTC ophthalmic solution in US marketDr Reddy's Laboratories has launched a new eye drop in the United States. This over-the-counter solution treats itchy eyes. It is an antihi...14 Jan, 2026, 10.51 PM IST
- Stocks in news: Angel One, Tata Steel, Shriram Finance, IndiGo, EternalMarkets extended their corrective phase on Wednesday, with the Nifty nearing support levels. Several companies are in focus today due to si...08 Jan, 2026, 06.40 AM IST
- Glenmark arm recalls products in US for manufacturing issuesGlenmark Pharmaceuticals is recalling 45,504 bottles of Ryaltris Nasal Spray and 11,568 tubes of Ciclopirox Gel in the US due to manufactur...13 Oct, 2024, 12.21 PM IST
- On a path to recovery; 7 mid-cap pharma stocks with an upside potential up to 47 %After the covid tailwinds got over, pharma stocks witnessed a phase of under-performance. However as the markets get jittery, select pharma...02 Mar, 2023, 01.04 PM IST
- These 5 midcap stocks with ‘strong buy’ & ‘buy’ ratings can rally over 25%, say analystsFor all those who are busy guessing what will happen to Adani group stocks, there is a market beyond Adani stocks and that is very large. E...09 Feb, 2023, 05.56 PM IST
- Defensive Bets: 4 midcaps from pharma sector with ‘Buy’ & ‘Strong Buy’ ratings have upside potential of up to 31%As NIFTY gets even more volatile, there are some sectors which are traditionally considered defensive and they tend to get attention when m...07 Feb, 2023, 02.46 PM IST
- Glenmark's partner Hikma launches specialty drug Ryaltris in USRyaltris is the only fixed-dose combination of olopatadine hydrochloride and mometasone furoate approved by the USFDA for the treatment of ...30 Aug, 2022, 07.21 PM IST
- Glenmark Pharmaceuticals acquires certain OTC drugs from Wockhardt in US"The over-the-counter market has long been an important segment of Glenmark's portfolio around the world. Our acquisition of these ANDAs re...28 Jun, 2022, 12.13 PM IST
- Dr Reddy's Laboratories launches over-the-counter eye allergy drop in USDr Reddy's said Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2 per cent and 0.1 per cent, are indicated for the temporary relief of...17 Sep, 2020, 12.29 PM IST
- Glenmark Pharma says USFDA has issued CRL for RyaltrisThe CRL cites deficiencies in the Drug Master File pertaining to one of the active pharmaceutical ingredients and in manufacturing faciliti...22 Jun, 2019, 03.49 PM IST
- Alembic Pharmaceuticals gets USFDA nod for ophthalmic solutionThe company has received approval from the USFDA for its abbreviated new drug application (ANDA) Olopatadine Hydrochloride ophthalmic solut...10 Dec, 2018, 12.14 PM IST
- Aurobindo Pharma gets USFDA nod for its conjunctivitis drugAurobindo Pharma has received approval from the USFDA nod for generic Olopatadine Hydrochloride ophthalmic solution used for treatment of c...22 Dec, 2015, 01.13 PM IST
- Wockhardt gets USFDA nod for generic eye dropsDrug maker Wockhardt said it has received tentative approval from the US health regulator to market Olopatadine hydrochloride eye drops in ...02 Jul, 2011, 04.42 AM IST
- Wockhardt receives USFDA approval for generic eye dropsDrug maker Wockhardt today said it has received tentative approval from the US health regulator.01 Jul, 2011, 02.11 PM IST
Load More
